 |
PDBsum entry 1wax
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Fragment-Based lead discovery using X-Ray crystallography.
|
 |
|
Authors
|
 |
M.J.Hartshorn,
C.W.Murray,
A.Cleasby,
M.Frederickson,
I.J.Tickle,
H.Jhoti.
|
 |
|
Ref.
|
 |
J Med Chem, 2005,
48,
403-413.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Fragment screening offers an alternative to traditional screening for
discovering new leads in drug discovery programs. This paper describes a
fragment screening methodology based on high throughput X-ray crystallography.
The method is illustrated against five proteins (p38 MAP kinase, CDK2, thrombin,
ribonuclease A, and PTP1B). The fragments identified have weak potency (>100
microM) but are efficient binders relative to their size and may therefore
represent suitable starting points for evolution to good quality lead compounds.
The examples illustrate that a range of molecular interactions (i.e.,
lipophilic, charge-charge, neutral hydrogen bonds) can drive fragment binding
and also that fragments can induce protein movement. We believe that the method
has great potential for the discovery of novel lead compounds against a range of
targets, and the companion paper illustrates how lead compounds have been
identified for p38 MAP kinase starting from fragments such as those described in
this paper.
|
 |
|
|
|
|
 |